2600MO Relevance of the CPS score and tumor nephrectomy in the SUNNIFORECAST trial comparing ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer. - Bergmann, L.; Albiges, L.; Ahrens, M.; Gross Goupil, M.; Boleti, E.; Gravis, G.; Flechon, A.; Grimm, M-O.; Bedke, J.; Barthelemy, P.; Castellano Gauna, D.E.; Mellado Gonzalez, B.; et al. (Annals of Oncology, 2025)